Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Escudier, B.
113  Ergebnisse:
Personensuche X
?
1

Everolimus or sunitinib as first-line treatment of metastat..:

Cancel, M ; Fromont, G ; Blonz, C...
10.1016/j.ejca.2021.08.046.  , 2024
Link: https://hdl.handle.net/2..
 
?
2

Nivolumab plus cabozantinib versus sunitinib for first-line..:

Powles, T ; Burotto, M ; Escudier, B...
Powles , T , Burotto , M , Escudier , B , Apolo , A B , Bourlon , M T , Shah , A Y , Suárez , C , Porta , C , Barrios , C H , Richardet , M , Gurney , H , Kessler , E R , Tomita , Y , Bedke , J , George , S , Scheffold , C , Wang , P , Fedorov , V , Motzer , R J & Choueiri , T K 2024 , ' Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma : extended follow-up from the phase III randomised CheckMate 9ER trial ' , ESMO Open , vol. 9 , no. 5 , 102994 , pp. 1-11 . https://doi.org/10.1016/j.esmoop.2024.102994.  , 2024
Link: https://researchers.mq.e..
 
?
3

Impact of COVID-19 pandemic on treatment patterns in metast..:

Aeppli, S ; Eboulet, EI ; Eisen, T...
ARTN e000852.  , 2022
Link: https://repository.icr.a..
 
?
4

First-line treatment of metastatic clear cell renal cell ca..:

Aeppli, S ; Schmaus, M ; Eisen, T...
ARTN 100030.  , 2022
Link: https://repository.icr.a..
 
?
5

External Validation of the 2003 Leibovich Prognostic Score ..:

Oza, B ; Eisen, T ; Frangou, E...
issn:0732-183X.  , 2022
Link: http://hdl.handle.net/11..
 
?
6

External Validation of the 2003 Leibovich Prognostic Score ..:

Oza, B ; Eisen, T ; Frangou, E...
Journal of Clinical Oncology, 2022, 40 (16), pp. 1772 - 1782.  , 2022
Link: https://repository.icr.a..
 
?
7

First-line treatment of metastatic clear cell renal cell ca..:

Aeppli, S ; Schmaus, M ; Eisen, T...
https://boris.unibe.ch/160787/.  , 2021
Link: https://boris.unibe.ch/1..
 
?
8

696O_PR Nivolumab + cabozantinib vs sunitinib in first-line..:

Choueiri, T.K ; Powles, T ; Burotto, M...
http://eprints.uanl.mx/22445/1/22445.pdf.  , 2020
Link: http://eprints.uanl.mx/2..
 
?
9

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate..:

Eisen, T ; Frangou, E ; Oza, B...
https://discovery.ucl.ac.uk/id/eprint/10112716/1/Meade_jco.20.01800.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
10

Cross-reactivity between tumor MHC class I–restricted antig..:

Fluckiger A ; Daillere R ; Sassi M...
info:eu-repo/semantics/altIdentifier/pmid/32820119.  , 2020
Link: http://hdl.handle.net/11..
 
?
11

Gut Bacteria Composition Drives Primary Resistance to Cance..:

Derosa L ; Routy B ; Fidelle M...
info:eu-repo/semantics/altIdentifier/pmid/32376136.  , 2020
Link: http://hdl.handle.net/11..
 
?
12

Renal cell carcinoma: ESMO Clinical Practice Guidelines for..:

Escudier, B ; Porta, C ; Schmidinger, M...
https://discovery.ucl.ac.uk/id/eprint/10074352/3/Bex_ESMOCPG-RenalCellCarcinoma-Manuscript.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
13

Metastatic Renal Cell Carcinoma Rapidly Progressive to Suni..:

Bersanelli M ; Iacovelli R ; Buti S...
info:eu-repo/semantics/altIdentifier/pmid/31331862.  , 2019
Link: http://hdl.handle.net/11..
 
?
14

LBA56: Primary efficacy analysis results from the SORCE tri..:

Eisen, TQG ; Frangou, E ; Smith, B...
https://discovery.ucl.ac.uk/id/eprint/10082787/3/Bex_LBA56.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
15

Renal cell carcinoma: ESMO Clinical Practice Guidelines for..:

Escudier B ; Porta C ; Schmidinger M...
info:eu-repo/semantics/altIdentifier/pmid/30788497.  , 2019
Link: http://hdl.handle.net/11..
 
1-15